3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Kaposi
1
HIV Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
Zidovudine
9
Doxorubicin
9
Vincristine
6
Bleomycin
6
Interferon alpha-2
5
Etoposide
5
tecogalan
4
Valganciclovir
4
Semaxinib
4
Liposomes
4
Ritonavir
3
Paclitaxel
3
Nelfinavir
3
Filgrastim
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
sargramostim
2
liposomal doxorubicin
2
interferon alfa-n1
2
Indinavir
2
Docetaxel
2
Didanosine
2
Alitretinoin
2
vesnarinone
1
valspodar
1
tocilizumab
1
tin etiopurpurin
1
pomalidomide
1
pembrolizumab
1
halofuginone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Kaposi
×
Emtricitabine
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled